-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Bersacapavir
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1638266-40-6.gif)
| Category | Hepatitis B Virus (HBV) |
| CAS | 1638266-40-6 |
| Description | Bersacapavir is an assembly modulator of hepatitis B virus capsid. |
Product Information
| Synonyms | JNJ-6379; JNJ-56136379; 1H-Pyrrole-2-carboxamide, N-(3-cyano-4-fluorophenyl)-1-methyl-4-((((1S)-2,2,2-trifluoro-1-methylethyl)amino)sulfonyl)-; N-(3-Cyano-4-fluorophenyl)-1-methyl-4-(((2S)-1,1,1-trifluoro-2-propanyl)sulfamoyl)-1H-pyrrole-2-carboxamide |
| IUPAC Name | N-(3-cyano-4-fluorophenyl)-1-methyl-4-[[(2S)-1,1,1-trifluoropropan-2-yl]sulfamoyl]pyrrole-2-carboxamide |
| Molecular Weight | 418.37 |
| Molecular Formula | C16H14F4N4O3S |
| Canonical SMILES | CC(C(F)(F)F)NS(=O)(=O)C1=CN(C(=C1)C(=O)NC2=CC(=C(C=C2)F)C#N)C |
| InChI | InChI=1S/C16H14F4N4O3S/c1-9(16(18,19)20)23-28(26,27)12-6-14(24(2)8-12)15(25)22-11-3-4-13(17)10(5-11)7-21/h3-6,8-9,23H,1-2H3,(H,22,25)/t9-/m0/s1 |
| InChIKey | SBVBIDUKSBJYEF-VIFPVBQESA-N |
| Purity | ≥98% |
| Density | 1.47±0.1 g/cm3 (Predicted) |
| Solubility | Soluble in DMSO |
| Appearance | Solid Powder |
| Storage | Store at -20°C |
| Complexity | 730 |
| Exact Mass | 418.07227414 |
| Index Of Refraction | 1.575 |
| Target | HBV |
| XLogP3-AA | 2.2 |
